Cognex Corporation (NASDAQ: CGNX) today reported financial results for 2020. Table 1 below shows selected financial data for Q4-20 compared with Q4-19 and Q3-20, and the year ended December 31, 2020 compared with the year ended December 31, 2019.
Table 1 (Dollars in thousands, except per share amounts) | ||||
|
Revenue |
Net Income |
Net Income | Non-GAAP |
Quarterly Comparisons |
|
|
|
|
Current quarter: Q4-20 | $223,615 | $69,345 | $0.39 | $0.32 |
Prior year’s quarter: Q4-19 | $169,769 | $80,327 | $0.46 | $0.11 |
Change: Q4-19 to Q4-20 | 32% | (14)% | (15)% | 191% |
Prior quarter: Q3-20 | $251,073 | $87,506 | $0.49 | $0.47 |
Change: Q3-20 to Q4-20 | (11)% | (21)% | (20)% | (32)% |
Yearly Comparisons |
|
|
|
|
Year ended December 31, 2020 | $811,020 | $176,186 | $1.00 | $1.09 |
Year ended December 31, 2019 | $725,625 | $203,865 | $1.16 | $0.80 |
Change from 2019 to 2020 | 12% | (14)% | (14)% | 36% |
*Non-GAAP net income per diluted share excludes restructuring and other charges that occurred predominantly in Q2-20, and tax adjustments for all periods presented. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.
“It’s hard to call 2020 a ‘good’ year, but we are, nevertheless, pleased with the financial results that we were able to achieve,” said Dr. Robert J. Shillman, Founder and Chairman of Cognex. “We set a new record for both Q4 and annual revenue despite significant economic disruption and weakness in the automotive industry. Importantly, we remained focused on long-term growth opportunities, which we believe has positioned us well going into 2021.”
“The past year was a turbulent time for most businesses, including Cognex,” said Robert J. Willett, Chief Executive Officer of Cognex. “We are proud of our achievements, and the continued dedication and hard work of Cognoids around the world during this difficult period. While economic conditions remain unpredictable, we are cautiously optimistic that the strength we experienced in the second half of 2020 will continue into the new year.”
Summary of the Year
Cognex reported record revenue of $811 million in 2020—representing an increase of 12% year-on-year―despite significant disruptions to the global economy during the year. Revenue growth was due to higher revenue from consumer electronics and the e-commerce fulfillment sector of logistics, and particularly from large customers that benefited from higher consumer demand during the COVID-19 pandemic. Revenue from medical-related industries also increased, though considerably less than the increase from consumer electronics and logistics.
Operating income on a GAAP basis was 21% of revenue compared to 20% for 2019 because of the higher revenue. Cognex remained focused on the long term and invested a record $131 million, or 16% of revenue, in engineering, marking the company’s tenth consecutive year of Research, Development and Engineering (RD&E) growth. We believe that our position as a leader in machine vision is due, in large part, to the engineering content in our products, and we intend to continue to invest in RD&E going forward. The company recorded pre-tax restructuring charges of approximately $16 million for steps taken to reduce expenses, including a workforce reduction and lease terminations. In addition, Cognex recorded non-cash charges of approximately $27 million in the second quarter for the impairment of intangible assets and write-down of excess and obsolete inventory due to the deteriorated business conditions. Excluding restructuring and other charges, operating income was 27% of revenue for 2020 compared to 20% in the prior year.
Details of the Quarter
Statement of Operations Highlights – Fourth Quarter of 2020
Balance Sheet Highlights – December 31, 2020
Financial Outlook – Q1 2021
Non-GAAP Financial Measures
Analyst Conference Call and Simultaneous Webcast
About Cognex Corporation
Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors, and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.
Cognex is the world's leader in the machine vision industry, having shipped more than 3 million image-based products, representing over $8 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.
Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance, the expected impact of the COVID-19 pandemic on our assets, business and results of operations, customer order rates and timing of related revenue, future product mix, restructuring and other cost-savings initiatives, research and development activities, capital projects, investments, acquisitions, liquidity, dividends and stock repurchases, strategic plans, and estimated tax benefits and expenses and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the impact, duration, and severity of the COVID-19 pandemic; (2) potential disruptions to our business due to restructuring activities; (3) the loss of, or curtailment of purchases by, large customers in the consumer electronics and logistics industries; (4) the reliance on revenue from the automotive industry; (5) the reliance on key suppliers to manufacture and deliver critical components for our products; (6) the failure to effectively manage product transitions or accurately forecast customer demand; (7) the inability to design and manufacture high-quality products; (8) the inability to attract and retain skilled employees and maintain our unique corporate culture; (9) the failure to effectively manage our growth; (10) the inability to achieve growth in revenue and profits from the logistics industry; (11) the technological obsolescence of current products and the inability to develop new products; (12) the failure to properly manage the distribution of products and services; (13) the impact of competitive pressures; (14) the challenges in integrating and achieving expected results from acquired businesses; (15) potential disruptions in our business systems; (16) information security breaches; (17) the inability to protect our proprietary technology and intellectual property; (18) potential impairment charges with respect to our investments or acquired intangible assets; (19) exposure to additional tax liabilities; (20) fluctuations in foreign currency exchange rates and the use of derivative instruments; (21) our involvement in time-consuming and costly litigation; (22) unfavorable global economic conditions; (23) economic, political, and other risks associated with international sales and operations; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2020. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.
Exhibit 1 | ||||||||||||||||||||||
COGNEX CORPORATION Statements of Operations (Unaudited) Dollars in thousands, except per share amounts | ||||||||||||||||||||||
| Three-months Ended |
| Twelve-months Ended | |||||||||||||||||||
| December 31, |
| September 27, |
| December 31, |
| December 31, |
| December 31, | |||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||||
Revenue | $ | 223,615 |
|
|
| $ | 251,073 |
|
| $ | 169,769 |
|
|
| $ | 811,020 |
|
| $ | 725,625 |
|
|
Cost of revenue (1) | 55,160 |
|
|
| 59,741 |
|
| 44,871 |
|
|
| 206,421 |
|
| 189,754 |
|
| |||||
Gross margin | 168,455 |
|
|
| 191,332 |
|
| 124,898 |
|
|
| 604,599 |
|
| 535,871 |
|
| |||||
Percentage of revenue | 75 |
| % |
| 76 | % |
| 74 |
| % |
| 75 | % |
| 74 |
| % | |||||
Research, development, and engineering | 34,399 |
|
|
| 30,240 |
|
| 32,991 |
|
|
| 130,982 |
|
| 119,427 |
|
| |||||
Percentage of revenue | 15 |
| % |
| 12 | % |
| 19 |
| % |
| 16 | % |
| 16 |
| % | |||||
Selling, general, and administrative expenses (1) | 74,096 |
|
|
| 64,206 |
|
| 74,300 |
|
|
| 267,593 |
|
| 273,842 |
|
| |||||
Percentage of revenue | 33 |
| % |
| 26 | % |
| 44 |
| % |
| 33 | % |
| 38 |
| % | |||||
Restructuring charges | 875 |
|
|
| 251 |
|
| — |
|
|
| 15,924 |
|
| — |
|
| |||||
Intangible asset impairment charges | — |
|
|
| — |
|
| — |
|
|
| 19,571 |
|
| — |
|
| |||||
Operating income | 59,085 |
|
|
| 96,635 |
|
| 17,607 |
|
|
| 170,529 |
|
| 142,602 |
|
| |||||
Percentage of revenue | 26 |
| % |
| 38 | % |
| 10 |
| % |
| 21 | % |
| 20 |
| % | |||||
Foreign currency gain (loss) | 4,007 |
|
|
| 2,357 |
|
| 894 |
|
|
| 3,697 |
|
| (509 | ) |
| |||||
Investment and other income | 1,828 |
|
|
| 2,317 |
|
| 4,420 |
|
|
| 12,685 |
|
| 20,901 |
|
| |||||
Income before income tax expense (benefit) | 64,920 |
|
|
| 101,309 |
|
| 22,921 |
|
|
| 186,911 |
|
| 162,994 |
|
| |||||
Income tax expense (benefit) | (4,425 | ) |
|
| 13,803 |
|
| (57,406 | ) |
|
| 10,725 |
|
| (40,871 | ) |
| |||||
Net income | $ | 69,345 |
|
|
| $ | 87,506 |
|
| $ | 80,327 |
|
|
| $ | 176,186 |
|
| $ | 203,865 |
|
|
Percentage of revenue | 31 |
| % |
| 35 | % |
| 47 |
| % |
| 22 | % |
| 28 |
| % | |||||
|
|
|
|
|
|
|
|
|
| |||||||||||||
Net income per weighted-average common and common-equivalent share: |
|
|
|
|
|
|
|
|
| |||||||||||||
Basic | $ | 0.40 |
|
|
| $ | 0.50 |
|
| $ | 0.47 |
|
|
| $ | 1.02 |
|
| $ | 1.19 |
|
|
Diluted | $ | 0.39 |
|
|
| $ | 0.49 |
|
| $ | 0.46 |
|
|
| $ | 1.00 |
|
| $ | 1.16 |
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Weighted-average common and common-equivalent shares outstanding: |
|
|
|
|
|
|
|
|
| |||||||||||||
Basic | 175,220 |
|
|
| 173,943 |
|
| 171,607 |
|
|
| 173,489 |
|
| 171,194 |
|
| |||||
Diluted | 178,590 |
|
|
| 177,138 |
|
| 175,500 |
|
|
| 176,592 |
|
| 175,269 |
|
| |||||
|
|
|
|
|
|
|
|
|
| |||||||||||||
Cash dividends per common share | $ | 2.060 |
|
|
| $ | 0.055 |
|
| $ | 0.055 |
|
|
| $ | 2.225 |
|
| $ | 0.205 |
|
|
Cash and investments per common share | $ | 4.37 |
|
|
| $ | 5.80 |
|
| $ | 4.90 |
|
|
| $ | 4.37 |
|
| $ | 4.90 |
|
|
Book value per common share | $ | 7.18 |
|
|
| $ | 8.62 |
|
| $ | 7.86 |
|
|
| $ | 7.18 |
|
| $ | 7.86 |
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
(1) Amounts include stock-based compensation expense, as follows: |
|
|
|
|
|
|
|
|
| |||||||||||||
Cost of revenue | $ | 324 |
|
|
| $ | 324 |
|
| $ | 390 |
|
|
| $ | 1,365 |
|
| $ | 1,504 |
|
|
Research, development, and engineering | 2,805 |
|
|
| 2,815 |
|
| 4,115 |
|
|
| 13,387 |
|
| 15,748 |
|
| |||||
Selling, general, and administrative | 7,456 |
|
|
| 6,129 |
|
| 7,642 |
|
|
| 27,909 |
|
| 28,337 |
|
| |||||
Total stock-based compensation expense | $ | 10,585 |
|
|
| $ | 9,268 |
|
| $ | 12,147 |
|
|
| $ | 42,661 |
|
| $ | 45,589 |
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 2 | ||||||||||||||||||||||||
COGNEX CORPORATION Reconciliation of Selected Items from GAAP to Non-GAAP (Unaudited) Dollars in thousands, except per share amounts | ||||||||||||||||||||||||
| Three-months Ended |
|
| Twelve-months Ended | ||||||||||||||||||||
| December 31, |
| September 27, |
| December 31, |
|
| December 31, |
| December 31, | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||
Discrete tax adjustments reconciliation |
|
|
|
|
|
|
| |||||||||||||||||
Income before income tax expense (benefit) (GAAP) | $ | 64,920 |
|
|
| $ | 101,309 |
|
|
| $ | 22,921 |
|
|
|
| $ | 186,911 |
|
| $ | 162,994 |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||
Income tax expense (benefit) (GAAP) | $ | (4,425 | ) |
|
| $ | 13,803 |
|
|
| $ | (57,406 | ) |
|
|
| $ | 10,725 |
|
| $ | (40,871 | ) |
|
Effective tax rate (GAAP) | (7 | ) | % |
| 14 |
| % |
| (250 | ) | % |
|
| 6 | % |
| (25 | ) | % | |||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||
Discrete tax benefit related to stock-based compensation | 2,342 |
|
|
| 4,354 |
|
|
| 1,925 |
|
|
|
| 12,788 |
|
| 6,472 |
|
| |||||
Discrete tax benefit (expense) related to tax return filings and other | 11,441 |
|
|
| (129 | ) |
|
| 602 |
|
|
|
| 7,803 |
|
| 1,932 |
|
| |||||
Discrete tax expense related to migration of acquired IP | — |
|
|
| — |
|
|
| (28,528 | ) |
|
|
| — |
|
| (28,528 | ) |
| |||||
Discrete tax benefit related to change in tax structure | — |
|
|
| — |
|
|
| 87,500 |
|
|
|
| — |
|
| 87,500 |
|
| |||||
Total discrete tax adjustments | $ | 13,783 |
|
|
| $ | 4,225 |
|
|
| $ | 61,499 |
|
|
|
| $ | 20,591 |
|
| $ | 67,376 |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||
Income tax expense (benefit) (Non-GAAP) | $ | 9,358 |
|
|
| $ | 18,028 |
|
|
| $ | 4,093 |
|
|
|
| $ | 31,316 |
|
| $ | 26,505 |
|
|
Effective tax rate (Non-GAAP) | 14 |
| % |
| 18 |
| % |
| 18 |
| % |
|
| 17 | % |
| 16 |
| % | |||||
|
|
|
|
|
|
|
|
|
|
|
Exclusion of restructuring and other charges |
|
|
|
|
|
|
| |||||||||||||
Operating income (GAAP) | $ | 59,085 |
|
| $ | 96,635 |
|
| $ | 17,607 |
|
|
| $ | 170,529 |
|
| $ | 142,602 |
|
Percentage of revenue (GAAP) | 26 | % |
| 38 | % |
| 10 | % |
|
| 21 | % |
| 20 | % | |||||
Excess and obsolete inventory charges | 522 |
|
| 603 |
|
| 1,175 |
|
|
| 9,908 |
|
| 5,296 |
| |||||
Restructuring charges | 875 |
|
| 251 |
|
| — |
|
|
| 15,924 |
|
| — |
| |||||
Intangible asset impairment charges | — |
|
| — |
|
| — |
|
|
| 19,571 |
|
| — |
| |||||
Operating income (Non-GAAP) | $ | 60,482 |
|
| $ | 97,489 |
|
| $ | 18,782 |
|
|
| $ | 215,932 |
|
| $ | 147,898 |
|
Percentage of revenue (Non-GAAP) | 27 | % |
| 39 | % |
| 11 | % |
|
| 27 | % |
| 20 | % | |||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||
|
|
|
|
|
|
|
|
|
|
|
Restructuring and other charges and discrete tax adjustments reconciliation |
|
|
|
|
|
|
| ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Net income (GAAP) | $ | 69,345 |
|
|
| $ | 87,506 |
|
|
| $ | 80,327 |
|
|
|
| $ | 176,186 |
|
|
| $ | 203,865 |
|
|
Excess and obsolete inventory charges | 522 |
|
|
| 603 |
|
|
| 1,175 |
|
|
|
| 9,908 |
|
|
| 5,296 |
|
| |||||
Restructuring charges | 875 |
|
|
| 251 |
|
|
| — |
|
|
|
| 15,924 |
|
|
| — |
|
| |||||
Intangible asset impairment charges | — |
|
|
| — |
|
|
| — |
|
|
|
| 19,571 |
|
|
| — |
|
| |||||
Tax effect on restructuring and other charges | (196 | ) |
|
| (154 | ) |
|
| (188 | ) |
|
|
| (7,719 | ) |
|
| (847 | ) |
| |||||
Discrete tax adjustments | (13,783 | ) |
|
| (4,225 | ) |
|
| (61,499 | ) |
|
|
| (20,591 | ) |
|
| (67,376 | ) |
| |||||
Net income (Non-GAAP) | $ | 56,763 |
|
|
| $ | 83,981 |
|
|
| $ | 19,815 |
|
|
|
| $ | 193,279 |
|
|
| $ | 140,938 |
|
|
Percentage of revenue (Non-GAAP) | 25 |
| % |
| 33 |
| % |
| 12 |
| % |
|
| 24 |
| % |
| 19 |
| % | |||||
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Net income per diluted weighted-average common and common-equivalent share (GAAP) | $ | 0.39 |
|
|
| $ | 0.49 |
|
|
| $ | 0.46 |
|
|
|
| $ | 1.00 |
|
|
| $ | 1.16 |
|
|
Per share impact of non-GAAP adjustments identified above | (0.07 | ) |
|
| (0.02 | ) |
|
| (0.35 | ) |
|
|
| 0.09 |
|
|
| (0.36 | ) |
| |||||
Net income per diluted weighted-average common and common-equivalent share (Non-GAAP) | $ | 0.32 |
|
|
| $ | 0.47 |
|
|
| $ | 0.11 |
|
|
|
| $ | 1.09 |
|
|
| $ | 0.80 |
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Diluted weighted-average common and common-equivalent shares outstanding | 178,590 |
|
|
| 177,138 |
|
|
| 175,500 |
|
|
|
| 176,592 |
|
|
| 175,269 |
|
| |||||
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
Exhibit 3 | |||||||
COGNEX CORPORATION Balance Sheets (Unaudited) Dollars in thousands | |||||||
| December 31, 2020 |
| December 31, 2019 | ||||
Assets |
|
|
| ||||
Cash and investments | $ | 767,438 |
|
| $ | 845,353 |
|
Accounts receivable | 125,696 |
|
| 103,447 |
| ||
Inventories | 60,830 |
|
| 60,261 |
| ||
Property, plant, and equipment | 79,173 |
|
| 89,443 |
| ||
Operating lease assets | 22,582 |
|
| 17,522 |
| ||
Goodwill and intangible assets | 259,633 |
|
| 282,935 |
| ||
Deferred tax assets | 434,704 |
|
| 449,519 |
| ||
Other assets | 50,646 |
|
| 37,455 |
| ||
|
|
|
| ||||
Total assets | $ | 1,800,702 |
|
| $ | 1,885,935 |
|
|
|
|
| ||||
Liabilities and Shareholders' Equity |
|
|
| ||||
Accounts payable and accrued expenses | $ | 93,534 |
|
| $ | 70,065 |
|
Deferred revenue and customer deposits | 21,274 |
|
| 14,432 |
| ||
Operating lease liabilities | 26,230 |
|
| 17,973 |
| ||
Income taxes | 72,551 |
|
| 93,009 |
| ||
Deferred tax liabilities | 314,952 |
|
| 332,344 |
| ||
Other liabilities | 9,959 |
|
| 2,402 |
| ||
Shareholders' equity | 1,262,202 |
|
| 1,355,710 |
| ||
|
|
|
| ||||
Total liabilities and shareholders' equity | $ | 1,800,702 |
|
| $ | 1,885,935 |
|
Last Trade: | US$39.95 |
Daily Change: | -0.03 -0.08 |
Daily Volume: | 420,784 |
Market Cap: | US$6.850B |
October 30, 2024 July 31, 2024 May 02, 2024 |
Surf Air Mobility is a regional air mobility platform expanding the category of regional air travel to reinvent flying through the power of electrification. In an effort to substantially reduce the cost and environmental impact of...
CLICK TO LEARN MOREElse Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS